Post Profile






High response rate in phase I/II pediatric brain cancer trial sets stage for combination therapy with higher response, lower toxicity

A high response rate with a single drug in a phase I/II trial of pediatric brain tumor has set the stage for combination therapy with higher response and lower toxicity, researchers report.
read more

share

Related Posts


New Drug Combination Shows Promise Against Childhood Brain Cancer

Health : Newswise Medical News

Researchers at SBP have identified a new combination therapy for the most aggressive form of medulloblastoma, a fast growing pediatric brain cancer. These results are expected to lead to a clinical trial.

Paving Way For Testing Therapy That Combines Brain Cancer Vaccine With The Drug Avastin

Health : Medical News Today

A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffe...

Immunogene Therapy Combined With Standard Treatment Is Safe For Patients With Brain Tumors

Health : Medical News Today

A clinical trial has shown that a form of gene therapy is safe for treating a deadly form of brain cancer, even when combined with radiation therapy. The phase 1b trial was conducted at the Ohio State University Comprehensive Cancer...

Novel Combination Therapy Developed at VCU Massey Cancer Center Shows Strong Response in Patients with Advanced Solid Tumors

Health : Newswise Medical News

A phase 1 clinical trial testing a novel combination therapy developed by scientists at VCU Massey Cancer Center slowed the growth of cancer in the majority of trial participants, which were patients with advanced solid tumors.

High response rate in phase I/II paediatric brain cancer trial

Health : EurekAlert: Health

(European Society for Medical Oncology) A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported...

Comments


Copyright © 2016 Regator, LLC